An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD

一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用

基本信息

项目摘要

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder marked by loss of motor neurons of the spinal cord and cortex. ALS is characterized by significant heterogeneity in disease onset and patient presentation. Over the last twenty years, mutations in over 35 different genes have been uncovered as causal in the development of familial forms of ALS (fALS); however, fALS only accounts for roughly 10% of all ALS cases. The remaining 90% of patients suffer from sporadic ALS (sALS), with no family history of disease and unknown causes of pathogenesis. Regardless of all this genetic and pathogenic complexity, remarkably nearly every single ALS patient (both fALS and sALS) share a common neuropathology in the form of aberrant cytoplasmic inclusions of a protein called TAR DNA-binding protein of 43 kDa (TDP-43) found in degenerating regions of the nervous system. Insight drawn from studies of fALS-linked mutations have implicated stress granule dysfunction in disease development, but the exact mechanisms by which the stress granules may directly regulate TDP-43 aggregation remains unclear. By utilizing a novel optogenetic approach to induce either TDP-43 inclusions or functional stress granules, we can manipulate these processes at a previously unattainable level of control. These experiments will explore the contribution of stress granule dysfunction to TDP-43 inclusion neurotoxicity. We hypothesize that perturbations in stress granule dynamics contribute to neurotoxic TDP-43 aggregation in ALS. We will first investigate the contribution of stress granules to light-induced TDP-43 inclusions. We will then determine if chronic or persistent stress granule formation initiates TDP-43 proteinopathy. Finally, we will perform a genome-wide RNAi screen to identify novel pathways that protect against TDP-43 inclusion toxicity and assess whether this protection is dependent on stress granule regulation.
肌萎缩侧索硬化症(ALS)是一种进行性、致命性神经退行性疾病, 脊髓和皮层运动神经元的丧失ALS的特征在于显著的 疾病发作和患者表现的异质性。在过去的二十年里,突变 在超过35种不同的基因中,已经发现它们在家族形式的发展中起着因果作用。 ALS(fALS);然而,fALS仅占所有ALS病例的约10%。其余 90%的患者患有散发性ALS(sALS),无家族病史, 发病原因。不管所有这些遗传和致病的复杂性, 几乎每一个ALS患者(fALS和sALS)都有一个共同的神经病理学, 一种称为TAR DNA结合蛋白的43 kDa蛋白质的异常细胞质内含物形式 (TDP-43)发现于神经系统的退化区域。从以下研究中得出的见解: fALS连锁突变涉及疾病发展中的应激颗粒功能障碍, 应激颗粒可能直接调节TDP-43聚集的确切机制 仍不清楚通过利用新的光遗传学方法诱导TDP-43包涵体或 功能应力颗粒,我们可以操纵这些过程在以前无法达到的 控制水平。这些实验将探索应激颗粒功能障碍对 TDP-43神经毒性。我们假设应力颗粒动力学中的扰动 导致ALS中神经毒性TDP-43聚集。我们将首先调查的贡献 应力颗粒形成光诱导TDP-43内含物。然后我们将确定是否慢性或 持续的应激颗粒形成引发TDP-43蛋白质病。最后,我们将执行一个 全基因组RNAi筛选,以确定防止TDP-43包含的新途径 毒性,并评估这种保护是否依赖于应激颗粒调节。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
  • DOI:
    10.1186/s13024-022-00585-1
  • 发表时间:
    2022-12-08
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
  • 通讯作者:
NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.
  • DOI:
    10.1038/s41467-022-31098-6
  • 发表时间:
    2022-06-13
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
  • 通讯作者:
Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo.
  • DOI:
    10.1016/j.nbd.2020.105078
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Otte, Charlton G.;Fortuna, Tyler R.;Mann, Jacob R.;Gleixner, Amanda M.;Ramesh, Nandini;Pyles, Noah J.;Pandey, Udai B.;Donnelly, Christopher J.
  • 通讯作者:
    Donnelly, Christopher J.
Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology.
  • DOI:
    10.7554/elife.67587
  • 发表时间:
    2021-05-26
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Anderson EN;Morera AA;Kour S;Cherry JD;Ramesh N;Gleixner A;Schwartz JC;Ebmeier C;Old W;Donnelly CJ;Cheng JP;Kline AE;Kofler J;Stein TD;Pandey UB
  • 通讯作者:
    Pandey UB
DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.
  • DOI:
    10.1007/s00401-021-02333-z
  • 发表时间:
    2021-09
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    Fortuna TR;Kour S;Anderson EN;Ward C;Rajasundaram D;Donnelly CJ;Hermann A;Wyne H;Shewmaker F;Pandey UB
  • 通讯作者:
    Pandey UB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher James Donnelly其他文献

Christopher James Donnelly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher James Donnelly', 18)}}的其他基金

Axonal TDP-43 Dysregulation in ALS and Dementia
ALS 和痴呆症中的轴突 TDP-43 失调
  • 批准号:
    10727012
  • 财政年份:
    2023
  • 资助金额:
    $ 37.22万
  • 项目类别:
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD
一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用
  • 批准号:
    10133164
  • 财政年份:
    2018
  • 资助金额:
    $ 37.22万
  • 项目类别:
An optogenetic approach to establish the interplay between stress granules and TDP-43 proteinopathy in ALS/FTD
一种光遗传学方法来确定 ALS/FTD 中应激颗粒与 TDP-43 蛋白病之间的相互作用
  • 批准号:
    10021191
  • 财政年份:
    2018
  • 资助金额:
    $ 37.22万
  • 项目类别:
Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS
ALS 中 C9orf72 和 Matrin 3 相互作用的分子机制
  • 批准号:
    9324387
  • 财政年份:
    2017
  • 资助金额:
    $ 37.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了